{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:43:22Z","timestamp":1784375002906,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jacadv.2025.102532","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:44:40Z","timestamp":1768308280000},"page":"102532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diastolic Dysfunction in Acute and Critical Illness"],"prefix":"10.1016","volume":"5","author":[{"given":"Tom","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Abbawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finlay","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Hothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesaven","family":"Dhamodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneesh","family":"Thilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gao-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonny","family":"Veenith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2025.102532_bib1","series-title":"StatPearls [Internet]","article-title":"Heart failure with preserved ejection fraction (HFpEF)","author":"Golla","year":"2025"},{"issue":"14","key":"10.1016\/j.jacadv.2025.102532_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032231","article-title":"Spironolactone reduces the risk of death in veterans with heart failure with preserved ejection fraction","volume":"13","author":"Kurgansky","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102532_bib3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/ijms25020794","article-title":"Heart failure with preserved, ejection fraction: the pathophysiological mechanisms behind the clinical phenotypes and the therapeutic approach","volume":"25","author":"Stoicescu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2025.102532_bib4","author":"Abdrams"},{"issue":"2 Suppl","key":"10.1016\/j.jacadv.2025.102532_bib5","article-title":"Heart failure with normal ejection fraction. The V-HeFT study. Veterans administration cooperative study group","volume":"81","author":"Cohn","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/clc.23754","article-title":"Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: a systemic review and metaanalysis","volume":"45","author":"Liang","year":"2022","journal-title":"Clin Cardiol"},{"issue":"18","key":"10.1016\/j.jacadv.2025.102532_bib7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102532_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102532_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.928232","article-title":"Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction","volume":"13","author":"Budde","year":"2022","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCRESAHA.124.323051","article-title":"Discovery of titin and its role in heart function and disease","volume":"136","author":"Granzier","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jacadv.2025.102532_bib11","article-title":"RBM20, a therapeutic target to alleviate, myocardial stiffness via titin isoforms switching in HFpEF","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102532_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cells14050324","article-title":"Molecular mechanisms underlying heart failure and their therapeutic potential","volume":"14","author":"Fonseka","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102532_bib13","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms23084195","article-title":"Remodeling and fibrosis of the cardiac muscle in the course of obesity-pathogenesis and involvement of the extracellular matrix","volume":"23","author":"Kruszewska","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCHEARTFAILURE.110.960054","article-title":"Transforming growth factor-\u03b2: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function","volume":"4","author":"Kapur","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102532_bib15","article-title":"Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment","volume":"2","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.102532_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.906272","article-title":"Endothelial dysfunction in heart failure with preserved ejection fraction: what are the experimental proofs?","volume":"13","author":"Cornuault","year":"2022","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102532_bib17","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ehf2.14626","article-title":"Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis","volume":"11","author":"D\u2019Amario","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014071","article-title":"Imaging targets to visualize the cardiac immune landscape in heart failure","volume":"16","author":"Wienecke","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2025.102532_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.709703","article-title":"The role of the inflammasome in heart failure","volume":"12","author":"Wu","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacadv.2025.102532_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117711","article-title":"The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mouse model","volume":"181","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000542633","article-title":"Cardiorenal syndrome in heart failure with preserved ejection fraction: insights into pathophysiology and recent advances","volume":"15","author":"Khandait","year":"2025","journal-title":"Cardiorenal Med"},{"issue":"12","key":"10.1016\/j.jacadv.2025.102532_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008322","article-title":"Incidence and outcomes of acute heart failure with preserved versus reduced ejection fraction in SPRINT","volume":"14","author":"Upadhya","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102532_bib23","author":"Hickey"},{"issue":"24","key":"10.1016\/j.jacadv.2025.102532_bib24","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.3390\/jcm11247362","article-title":"Acute and long-term cardiovascular complications among patients with sepsis and septic shock","volume":"11","author":"Merdji","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00134-024-07748-2","article-title":"Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock","volume":"51","author":"Vignon","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacadv.2025.102532_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.854421","article-title":"Mechanisms of post-critical illness, cardiovascular disease","volume":"9","author":"Owen","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102532_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurheartj\/ehr351","article-title":"Diastolic dysfunction and mortality in severe sepsis and septic shock","volume":"33","author":"Landesberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102532_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.chest.2017.10.032","article-title":"Evaluation of left ventricular diastolic function by the intensivist","volume":"153","author":"Greenstein","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102532_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10877-020-00620-w","article-title":"Prognostic value and time course evolution left ventricular global longitudinal strain in septic shock: an exploratory prospective study","volume":"35","author":"Bazalgette","year":"2021","journal-title":"J Clin Monit Comput"},{"issue":"11","key":"10.1016\/j.jacadv.2025.102532_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003865","article-title":"Left ventricular systolic longitudinal function as predictor of outcome in patients with sepsis","volume":"8","author":"Palmieri","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chstcc.2024.100050","article-title":"Characterizing cardiac function in ICU survivors of sepsis: a pilot study protocol","volume":"2","author":"Garrity","year":"2024","journal-title":"CHEST Crit Care"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13613-021-00937-y","article-title":"Long-term cardiovascular complications following sepsis: is senescence the missing link?","volume":"11","author":"Merdji","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102532_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028882","article-title":"Describing sepsis as a risk factor for cardiovascular disease","volume":"12","author":"Wardi","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40001-022-00761-5","article-title":"Factors associated with left ventricular diastolic dysfunction in patients with septic shock","volume":"27","author":"Ge","year":"2022","journal-title":"Eur J Med Res"},{"issue":"17","key":"10.1016\/j.jacadv.2025.102532_bib36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.120.047873","article-title":"Risk of cardiovascular events after spouse\u2019s ICU admission","volume":"142","author":"Ohbe","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31083\/j.rcm2401001","article-title":"SGLT2 inhibition in heart failure with preserved ejection fraction - the new frontier","volume":"24","author":"Aguiar-Neves","year":"2023","journal-title":"Rev Cardiovasc Med"},{"issue":"15","key":"10.1016\/j.jacadv.2025.102532_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102532_bib39","doi-asserted-by":"crossref","DOI":"10.3904\/kjim.2020.105","article-title":"Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence","volume":"35","author":"Choi","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"12","key":"10.1016\/j.jacadv.2025.102532_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"10458","key":"10.1016\/j.jacadv.2025.102532_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2025.102532_bib42","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2024.10","article-title":"Evidence for aldosterone antagonism in heart failure","volume":"10","author":"Sethi","year":"2024","journal-title":"Card Fail Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jacadv.2025.102532_bib43","article-title":"Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction","volume":"26","author":"Temporelli","year":"2024","journal-title":"Eur Heart J Suppl"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10.1016\/j.jacadv.2025.102532_bib45","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/jcm13092534","article-title":"Endothelial dysfunction in heart failure: what is its role?","volume":"13","author":"Drera","year":"2024","journal-title":"J Clin Med"},{"issue":"37","key":"10.1016\/j.jacadv.2025.102532_bib46","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102532_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100452","article-title":"Automated echocardiographic detection of heart failure with preserved ejection fraction using artificial intelligence","volume":"2","author":"Akerman","year":"2023","journal-title":"JACC Adv"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102532_bib48","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0735-1097(97)00384-7","article-title":"Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients","volume":"30","author":"Stein","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2025.102532_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100447","article-title":"Artificial intelligence to aid early detection of heart failure with preserved ejection fraction","volume":"2","author":"Gevaert","year":"2023","journal-title":"JACC Adv"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102532_bib50","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1038\/s41467-025-58283-7","article-title":"External validation of artificial intelligence for detection of heart failure with preserved ejection fraction","volume":"16","author":"Akerman","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacadv.2025.102532_bib51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fphar.2017.00318","article-title":"Novel anti-fibrotic therapies","volume":"8","author":"McVicker","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25009615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25009615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:50:49Z","timestamp":1772509849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25009615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2772963X25009615"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102532","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diastolic Dysfunction in Acute and Critical Illness","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102532"}}